Previous close | 0.7500 |
Open | 0.7500 |
Bid | 0.7000 |
Ask | 1.2000 |
Strike | 2.50 |
Expiry date | 2024-07-19 |
Day's range | 0.7500 - 0.7500 |
Contract range | N/A |
Volume | |
Open interest | 59 |
Despite a dip in product sales, PTN progresses in clinical developments and maintains a stable financial footing.
Q3 2024 Palatin Technologies Inc Earnings Call
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced financial results for its fiscal third quarter ended March 31, 2024.